Dose rate and fractionation of total body irradiation in dogs: short and long term effects.
Variations of regimens of total body irradiation (TBI) were investigated in the dog as a preclinical model for bone marrow transplantation. Inactivation of hemopoietic precursor cells (CFU-GM) was studied following irradiation of marrow in vitro, following TBI at sublethal doses in vivo and following autologous transplantation of marrow obtained after sublethal TBI. Inactivation and recovery of CFU-GM as well as restoration of hemopoiesis following autologous transplantation was independent of the dose rate, but nadirs of blood counts were lower following sublethal TBI with the higher dose rate. Acute non-hemopoietic toxicity of TBI depended on the dose, the dose rate and the total treatment time and not on the fractionation regimen. At a total dose of 25 Gy acute mortality was prevented by prophylactic administration of oral, non-absorbable antibiotics. Late mortality was due to degenerative and autoimmune-like disorders with or without infections and to malignant tumors. Evaluation of long-term survival is still preliminary, since surviving dogs of two groups (10 Gy as single dose, 25 Gy as hyperfractionated TBI) have not yet reached the median survival time of their group. So far, long-term survival depended on the total dose (p = 0.05) and, possibly, the fractionation regimen (p = 0.12). The latency period until development of malignant tumors was influenced by the total doses given in the same treatment time (p = 0.05) and by the total treatment time for equal doses (p = 0.04). It was concluded that TBI at a low dose rate may give the best therapeutic ratio of inactivation of hemopoietic precursor cells to acute toxicity.(ABSTRACT TRUNCATED AT 250 WORDS)
Kolb
H J
HJ
Institut für Immunologie, Gesellschaft für Strahlen- und Umweltforschung, München, F.R.G.
Lösslein
L K
LK
Beisser
K
K
Schäffer
E
E
Holler
E
E
Schwella
N
N
Hochhäusser
E
E
Lehmacher
W
W
Balk
O
O
Thierfelder
S
S
D000818:Animals; D016026:Bone Marrow Transplantation; D002985:Clinical Protocols; D004285:Dogs; D005260:Female; D006412:Hematopoietic Stem Cells / Q000528:radiation effects*; D008297:Male; D011879:Radiotherapy Dosage; D013997:Time Factors; D014916:Whole-Body Irradiation / Q000379:methods*